Protontherapy at INFN-LNS C.Agodi Laboratori Nazionali del Sud - Catania LEA-COLLIGA – IPN Orsay November 14-16 2011.

Slides:



Advertisements
Similar presentations
Cirrone G. A. P. , Cuttone G. , Raffaele L. , Sabini M. G
Advertisements

Centro di AdroTerapia e Applicazioni Nucleari Avanzate Project for the development of a protontherapy facility Collaboration between INFN-Laboratori Nazionali.
Monte Carlo Based Implementation of an Energy Modulation System for Proton Therapy G.A.P. Cirrone Qualified Medical Physicist PhD Laboratori Nazionali.
Giorgio Russo National Research Council, Institute of Bioimaging and Molecular Imaging (IBFM) Fondazione Istituto San Raffaele G. Giglio di Cefalù Istituto.
F. Foppiano, M.G. Pia, M. Piergentili Medical Linac IEEE NSS, October 2004, Rome, Italy
GEANT4 simulation of an ocular proton beam & benchmark against MC codes D. R. Shipley, H. Palmans, C. Baker, A. Kacperek Monte Carlo 2005 Topical Meeting.
Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator.
Experience, Expertise and a Commitment to Excellence™
Dose Calculations A qualitative overview of Empirical Models and Algorithms Hanne Kooy.
MONTE-CARLO TECHNIQUES APPLIED TO PROTON DOSIMETRY AND RADIATION SAFETY F. Guillaume, G. Rucka, J. Hérault, N. Iborra, P. Chauvel 1 XXXV European Cyclotron.
Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.
ECPM 2006, Nice, France, 2-4 November DESIGN STUDIES OF THE 300AMEV SUPERCONDUCTING CYCLOTRON FOR HADRONTHERAPY Mario Maggiore Laboratori Nazionali.
Study of the fragmentation of Carbon ions for medical applications Protons (hadrons in general) especially suitable for deep-sited tumors (brain, neck.
NPL’s activities dosimetry for proton and ion therapy Hugo Palmans Radiation Dosimetry Team, National Physical Laboratory, Middlesex, UK
Part 1 Introduction to Radiotherapy and External Beam Radiation Deepak Khuntia, MD Vice President, Medical Affairs Varian Medical Systems.
Radiation oncology at JINR in brief Dzhelepov Laboratory of Nuclear Problems Joint Institute for Nuclear Research, Dubna, Russia  Accelerator technique.
Budker Inst. of Physics IHEP Protvino MEPHI Moscow Pittsburg University.
BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1,
DOSIMETRY COMMISSIONING OF THE LNS-INFN PROTON THERAPY FACILITY THE DOSIMETRIC CHARACTERISTICS OF NARROW PROTON BEAMS USED IN EYE THERAPY HAVE BEEN DEFINED.
Radiation therapy is based on the exposure of malign tumor cells to significant but well localized doses of radiation to destroy the tumor cells. The.
به نام خداوند بخشایندۀ بخشایشگر
Particle Physics Software aids Medicine Accurate geometry and material modeling in the fight against cancer Precise physics models for radiation interactions.
TWO FIELD BREAST PLAN VS. OPTIMIZED CONFORMAL BREAST PLAN: COMPARISON OF PLAN PARAMETERS Authors: Borko Basarić, Ozren Čudić, Milan Teodorović, Borislava.
A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.
RESPONSE OF A RESISTANT HUMAN MELANOMA CELL LINE TO A THERAPEUTIC PROTON BEAM A. Ristić-Fira 1, I Petrović 1, D. Todorović 1, L. Korićanac 1, L. Valastro.
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme Charged Particle Therapy Treating cancer with protons and light ions Ken Peach,
Augen-Tumor-Therapie mit 68 MeV Protonen am Hahn-Meitner-Institut Berlin C.Rethfeldt / SF4-ATT 1. Ionenstrahllabor ISL 2. Augen-Tumor-Therapie als Anwendung.
INFSO-RI Enabling Grids for E-sciencE Gilda experiences and tools in porting application Giuseppe La Rocca INFN – Catania ICTP/INFM-Democritos.
Научно-практический центр протонной лучевой терапии и радиохирургии (Москва-Дубна) A SYSTEM FOR MEASUREMENT OF A THERAPEUTIC PROTON BEAM DOSE DISTRIBUTION.
Test of the proposed method Introduction CCD Controller CCD Illuminator gel Filter 585nm Assembling the phantom before its irradiation. The phantom, ready.
Medical requirements for FFAG as proton beam sources Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE FFAG 2007, April 12-17, 2007.
1 GEANT4: Applications in Medical Physics B. Caccia Department of Technology and Health Istituto Superiore di Sanità (Italian National Institute of Health)
Joseph Perl SLAC National Accelerator Laboratory Scientific Computing Workshop 20 June 2011 Work supported in part by the U.S. Department of Energy under.
The Magic Cube and the Pixel Ionization Chamber: detectors for monitor and dosimetry of radiotherapy beams S. Amerio 1, A. Boriano 2, F. Bourhaleb 2,3,
Medical Accelerator F. Foppiano, M.G. Pia, M. Piergentili
APPLICATION TO THE HADROTHERAPY FOR OCULAR MELANOMAS G.A. Pablo Cirrone Qualified Medical Physicist and PhD Student University of Catania and Laboratori.
ARDENT Advanced Radiation Dosimetry European Network Training initiative WP1: Gas Detectors S. Rollet.
1 Radiotherapy, hadrontherapy and treatment planning systems. Faiza Bourhaleb INFN-Torino University Med 1er-Morocco  Radiotherapy  Optimization techniques.
USE OF GEANT4 CODE FOR VALIDATION OF RADIOBIOLOGICAL PARAMETERS OBTAINED AFTER PROTON AND CARBON IRRADIATIONS OF MELANOMA CELLS Ivan Petrović 1, Giuseppe.
TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.
Present & Future of Accelerators for Hadrontherapy A. Faus-Golfe IFIC-IFIMED June 20091IFIMED'09 Symposium.
The Use of Accelerator Beams for Calibration and Characterization of Solid State Nuclear Track Detectors Eric Benton Department of Physics Oklahoma State.
F. Foppiano, M.G. Pia, M. Piergentili
Introduction to Radiation Therapy
TLD POSTAL DOSE QUALITY AUDIT FOR 6MV AND 15MV PHOTON BEAMS IN RADIOTHERAPY CLINICAL PRACTICE Sonja Petkovska 1, Margarita Ginovska 2, Hristina Spasevska.
FrontierScience G.P.1 MATRIX an innovative Pixel Ionization Chamber for Online Monitoring of Hadrontherapy Treatments Giuseppe Pittà.
Implementation of a New Monte Carlo Simulation Tool for the Development of a Proton Therapy Beam Line and Verification of the related Dose Distributions.
Report on the completion of theme /2009 "Further Development of Methods and Instrumentation for Radiotherapy and Associated Diagnostics.
Experimental Cave at Trento CPT: status update Francesco Tommasino RDH/IRPT Meeting – Roma, 1 Feb 2016.
Thickness of CZT detector 110 MeV140 MeV DETECTOR A (1 mm CZT + 5 mm CZT) DETECTOR B (1 mm CZT + 10 mm CZT) DETECTOR C (1 mm CZT + 15 mm CZT) A. Generation.
The Australian Hadron Therapy and Research Facility.
HADRONTHERAPY IN ROMANIA NICOLAE IOAN VERGA M.D., Ph.D., D.Sc. “CAROL DAVILA” UNIVERSITY OF MEDICINE AND PHARMACY, ROMANIAN SOCIETY OF HADRONTHERAPY BUCHAREST,
Koichi MurakamiGeant4 Physics Verification and Validation (17-19/Jul./2006) 1 Results from the recent carbon test beam at HIMAC Koichi Murakami Statoru.
Development of elements of 3D planning program for radiotherapy Graphical editor options  automated enclose of contour  correction of intersections 
E. Mezzenga 1, E. Cagni 1, A. Botti 1, M. Orlandi 1, W.D. Renner 2, M. Iori 1 1. Medical Physics Unit, ASMN-IRCCS of Reggio Emilia, Italy 2. MathResolution.
CONFIDENTIAL MATERIAL Michele Togno - II Annual ARDENT Meeting, Milan – October, 14 th D Ionization Chambers Array for Clinical Applications.
12 C fragmentation measurements for hadrontherapy applications Introduction Status French program Japanese-French collaboration.
Multidisciplinary irradiation beam lines The CATANA proton therapy line The “0 degree” line The CATANA proton therapy line The “0 degree” line LNS Users.
Progress in the Application
INTERCOMPARISON P3. Dose distribution of a proton beam
EURADOS Working Group 9: Radiation Dosimetry in Radiotherapy
Press release Release of ISOgray Proton Treatment Planning System
A Comparative Study of Biological Effects of VHEE, Protons and other Radiotherapy Modalities Kristina Small University of Manchester, Christie NHS Foundation.
M. D. Anderson Cancer Center Houston, TX
APPLICATION TO THE HADROTHERAPY FOR OCULAR MELANOMAS
Geant4 physics validation: Bragg Peak
The Hadrontherapy Geant4 advanced example
Geant4 at IST Applications in Brachytherapy
Innovations in the Radiotherapy of Non–Small Cell Lung Cancer
Presentation transcript:

Protontherapy at INFN-LNS C.Agodi Laboratori Nazionali del Sud - Catania LEA-COLLIGA – IPN Orsay November

2. INFN & HADRONTHERAPY: THE CATANA PROTON THERAPY CENTER Beam line elements The DOSIMETRIC COMMISIONING: Absolute and relative dosimetry Treatment procedure Patient’s follow up 3. ACTUAL STATUS OF HADRONTHERAPY: THE CATANA SPIN-OFF OUTLINEOUTLINE 1. Why proton beams in tumour radiation treatment

2. INFN & HADRONTHERAPY: THE CATANA PROTON THERAPY CENTER Beam line elements The DOSIMETRIC COMMISIONING: Absolute and relative dosimetry Treatment procedure Patient’s follow up 3. ACTUAL STATUS OF HADRONTHERAPY: THE CATANA SPIN-OFF OUTLINEOUTLINE 1. Why proton beams in tumour radiation treatment

LNS LNS Depth dependence of the deposited dose for different radiation Why clinical hadron beam? Higher precision and greater biological effectiveness of the applied dose Because of the Bragg peak, protons dose distribution is “inverted” with respect to the almost exponential behaviour produced by a beam of high energy photons. The surface dose is low when compared to the dose absorbed in the region of the peak, at variance with what happens with photons and electrons.

penetration depth is well-defined and adjustable most energy at end-of -range protons travel in straight lines dose to normal tissue minimised no dose beyond target PROTONS PERMIT TO DELIVER AN HIGH DOSE TO THE TUMOUR SPARING THE SOURRONDING TISSUES Why clinical proton beam?

Between the eyes Intensity Modulateted Radiation Therapy vs PROTONS Abdomen Brain

PT faces a fast growing demand! PT center under operation LNS LNS C.Tobias and J.Lowrence: first therapeutic exposure of human patients to hadron beams at the Radiation Laboratory of California, Berkeley 1957 – Protons treatments : University of Uppsala, Sweden 1961 – Massachusetts General Hospital-Harvard Cyclotron Laboratory,USA 1967 – Dubna, 1969 Moscow, 1975 St Petersbourg in Russia 1979 – Chiba, 1983 Tsukuba in Japa 1984 – PSI-Villigen in Switzerland The Loma Linda University Medical Centre in California heralded the age of “dedicated” medical accelerators with commissioned its proton therapy facility with a 250 MeV Synchroton

2. INFN & HADRONTHERAPY: THE CATANA PROTON THERAPY CENTER Beam line elements The DOSIMETRIC COMMISIONING: Absolute and relative dosimetry Treatment procedure Patient’s follow up 3. ACTUAL STATUS OF HADRONTHERAPY: THE CATANA SPIN-OFF OUTLINEOUTLINE 1. Why proton beams in tumour radiation treatment

In 90’ years INFN supported TERA in R&D project. INFN, in collaboration with University of Catania, realized in its laboratory (Lab. Naz. Del Sud) the first Italian protontherapy facility. INFN has UNIQUE capability in Italy in accelerators development. Considering its particular features, INFN was involved in CNAO to guarantee the necessary expertise. In 2005 INFN was encharged by Health Minister to produce a document about protontherapy in our country. INFN & Hadrotherapy

In Catania we developed a facility (named CATANA) for the treatment of ocular tumours with 62 AMeV proton beams

LNS Superconducting Cyclotron is the unique machine in in Italy and South Europe used for protontherapy Treatment of the choroidal and iris melanoma In Italy about 300 new cases for year

CATANA LNS Accelerator Layout Ocular Protontherapy Unique Italian Facility

CATANA proton therapy beam line ( until June 2004 )

CATANA proton therapy beam line ( new location )

2. INFN & HADRONTHERAPY: THE CATANA PROTON THERAPY CENTER Beam line elements The DOSIMETRIC COMMISIONING: Absolute and relative dosimetry Treatment procedure Patient’s follow up 3. ACTUAL STATUS OF HADRONTHERAPY: THE CATANA SPIN-OFF OUTLINEOUTLINE 1. Why proton beams in tumour radiation treatment

Scattering system Modulator & Range shifter Monitor chambers Ligth field Laser CATANA proton therapy beam line

Lateral dose distribution in a clinical proton beam 95 % 50 % 20 %

Depth dose distribution – Energy modulation Generation of the Spread Out Bragg Peak (SOBP)

2. INFN & HADRONTHERAPY: THE CATANA PROTON THERAPY CENTER Beam line elements The DOSIMETRIC COMMISIONING: Absolute and relative dosimetry Treatment procedure Patient’s follow up 3. ACTUAL STATUS OF HADRONTHERAPY: THE CATANA SPIN-OFF OUTLINEOUTLINE 1. Why proton beams in tumour radiation treatment

Absolute Dosimetry: Energy Released in Water (Gray) Relative Dosimetry: Three dimensional dose distribution measurements  Considering the high gradient dose, conformation and small fields often used the detectors have to be kindly characterized in terms of spatial resolution, energy or fluence dependence to be used in protontherapy. Dosimetric commissioning: absolute & relative dosimetry Relative and Absolute Dosimetry are fundamental for: Customizing of TPS Monitor Unit Calculation Quality Control

ICRU 59 AND TRS 398 IAEA RECOMMENDATION  “ FOR MEASUREMENTS OF DEPTH-DOSE DISTRIBUTION IN PROTON BEAMS THE USE OF PLANE-PARALLEL CHAMBERS IS RECOMMENDED”  Parallel plate MARKUS PTW is the golden standard for depth dose measurements Dosimetric commissioning: absolute & relative dosimetry

Monte Carlo Simulation of the entire beam line using GEANT4: Improvement of our beam line and dosimetry Give a general purpose tool for the design of new hadron- therapy beam line Validation of the treatment system software GEANT4 simulation GEANT4 Simulation

2. INFN & HADRONTHERAPY: THE CATANA PROTON THERAPY CENTER Beam line elements The DOSIMETRIC COMMISIONING: Absolute and relative dosimetry Treatment procedure Patient’s follow up 3. ACTUAL STATUS OF HADRONTHERAPY: THE CATANA SPIN-OFF OUTLINEOUTLINE 1. Why proton beams in tumour radiation treatment

 The Surgical Phase  The Treatment Planning Phase  The Verification Phase  The Treatment Phase A typical treatment

Two orthogonal X-Rays tubes for the visualization of the clips

Lay-out of the axial X-Ray flat panel with its moving system Hamamatsu X- Ray axial flat panel NEW X-RAY SYSTEM FOR PATIENTS POSITIONING

EYEPLAN Originally developed by Michael Goitein and Tom Miller (Massachussetts General Hospital), is now maintained by Martin Sheen (Clatterbridge Center for Oncology) and Charle Perrett (PSI) Treatment Planning System Phase

This point is chosen in order to spare the organs at risk, and to maintain the best polar angle. Fixation Point Choice

 Fixation Light   Polar Angle  Azimuthal Angle Isocenter Fixation Point

Isodoses curves for different planes Treatment Planning System Output

At the end of patient positioning phase the radiotherapist draws the eye’s contour on a dedicated monitor in order to monitoring in any moment the eye’s position during the treatment. Dose: 15.0 CGE per day Fractions: 4 Treatment Time: sec. Total Dose: 60 CGE Treatment Phase TREATMENT MODALITIES

2. INFN & HADRONTHERAPY: THE CATANA PROTON THERAPY CENTER Beam line elements The DOSIMETRIC COMMISIONING: Absolute and relative dosimetry Treatment procedure Clinical results 3. ACTUAL STATUS OF HADRONTHERAPY: THE CATANA SPIN-OFF OUTLINEOUTLINE 1. Why proton beams in tumour radiation treatment

Patient Distribution by Pathologies Uveal Melanoma 164 patients Conjunctival Melanoma4 patients Conjunctival rhabdomyosarcoma 1 patient Eyelid Carcinoma and metastases 2 patient Conjunctival MALT-NHL1 patient Conjunctival Papilloma2 patient TOTAL PATIENTS 174

Total number of patients : 230 Since feb 2002 Patient Distribution by Origin Region 2 1

Patient Distribution by Sex The patients’age ranges between 14yrs and 81yrs (the mean age is 48 yrs)

PatientsTotal Number (April 2009) 174 Patients with Follow up138 TUMORAL THICKNESS ECOGRAPHIC REFLECTIVITY Reduced 70 % Increased77 % Stable24 %Stable18 % Increased2 %Not evaluable5 % Not evaluable2 % PATIENTS FOLLOW-UP (March 2002 – November 2008)

SURVAIVAL RESULTS PatientsTotal Number (April 2009) 174 Dead patients4 Metastatis3 Other1 Eye retention rate95 % TOTAL SURVIVAL98 % LOCAL CONTROL95 %

2. INFN & HADRONTHERAPY: THE CATANA PROTON THERAPY CENTER Beam line elements The DOSIMETRIC COMMISIONING: Absolute and relative dosimetry Treatment procedure Patient’s follow up 3. ACTUAL STATUS OF HADRONTHERAPY: THE CATANA SPIN-OFF OUTLINEOUTLINE 1. Why proton beams in tumour radiation treatment

CATANA Spin-off: Some Important Milestones In 2002, the First Italian Protontherapy Facility Funded by INFN and Catania University started in Catania at INFN-Laboratori Nazionali del Sud Sicilian Region has approved to realize an HadronTherapy Center in Catania, for protons and heavy charge particles. It has to be realized as “Scientific collaboration between Region, INFN and University of Catania also open to private contributions”

What is in progress? Proton computed tomography (PCT) Carbon beams for therapy… Lithium beams for therapy? …….

Remarks Knowledge gained from basic research influenced the choices of ion, energy, beam delivery system and treatment schedule. Moreover radiotherapy shall be developed only on the basis of research conducted according to the highest standard of scientific inquiry and using the most advanced method available.